XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ (1,623) $ 4,542
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Investment related (gains) losses on sale of investments and other assets 2,894 (963)
Net deferred policy acquisition cost (4,202) (4,293)
Amortization of cost of insurance acquired 98 172
Depreciation 161 144
Amortization of premiums and discounts on investments 1,181 1,291
Stock-based compensation 572 154
Deferred federal income tax expense (benefit) (370) (143)
Change in:    
Accrued investment income 289 70
Reinsurance recoverable (990) (217)
Due premiums 2,260 1,384
Future policy benefit reserves (3,495) 128
Other policyholders' liabilities 11,491 6,929
Federal income tax receivable 206 1,353
Commissions payable and other liabilities (7,855) (1,863)
Other, net 131 (1,900)
Net cash provided by operating activities 748 6,788
Cash flows from investing activities:    
Purchases of fixed maturity securities, available-for-sale (17,519) (23,271)
Sales of fixed maturity securities, available-for-sale 65 2,508
Maturities and calls of fixed maturity securities, available-for-sale 8,402 12,366
Principal payments on mortgage loans 2 3
(Increase) decrease in policy loans, net 255 85
Sales of other long-term investments 232 82
Purchases of other long-term investments (2,763) (1,181)
Purchase of property and equipment (107) (58)
Net cash used in investing activities (11,433) (9,466)
Cash flows from financing activities:    
Annuity deposits 2,211 1,600
Annuity withdrawals (2,385) (2,650)
Other share repurchases (57) (27)
Net cash used in financing activities (231) (1,077)
Net increase (decrease) in cash and cash equivalents (10,916) (3,755)
Cash and cash equivalents at beginning of year 29,271 26,997
Cash and cash equivalents at end of period $ 18,355 $ 23,242